Other Income/Expenses (Net)

$107.30M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$107.30Mperiod endingJun 30, 2026

REGN Quarterly Other Income/Expenses (Net) ($0.00 → $107.30M)

Quarterly Other Income/Expenses (Net)

High-resolution chart · PNG

REGN other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Other Income/Expenses (Net) — Quarterly (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2001	18,085,000
Mar 31, 2001	14,711,000
Dec 31, 2000	9,510,000
Sep 30, 2000	15,487,000
Jun 30, 2000	3,882,000
Mar 31, 2000	8,480,000
Dec 31, 1999	700,000
Sep 30, 1999	200,000
Jun 30, 1999	8,400,000
Mar 31, 1999	10,400,000
Dec 31, 1998	700,000
Sep 30, 1998	2,400,000
Jun 30, 1998	-700,000
Mar 31, 1998	1,100,000
Dec 31, 1997	-1,200,000
Sep 30, 1997	1,100,000
Jun 30, 1997	3,700,000
Mar 31, 1997	4,100,000
Dec 31, 1996	0
Sep 30, 1996	4,400,000
Jun 30, 1996	3,700,000
Mar 31, 1996	4,700,000
Dec 31, 1995	2,700,000
Sep 30, 1995	2,400,000
Jun 30, 1995	1,300,000
Mar 31, 1995	1,200,000
Dec 31, 1994	5,100,000
Sep 30, 1994	3,700,000
Jun 30, 1994	10,000,000
Mar 31, 1994	10,400,000
Dec 31, 1993	11,200,000
Sep 30, 1993	9,300,000
Jun 30, 1993	9,800,000
Mar 31, 1993	9,200,000
Dec 31, 1992	6,100,000
Sep 30, 1992	5,600,000
Jun 30, 1992	3,500,000
Mar 31, 1992	3,200,000
Dec 31, 1991	1,600,000
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0